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INTRODUCTION
Chronic liver disease is a worldwide major problem and 
alcohol is the leading cause of  chronic liver disease in 
western societies, while hepatitis B and C viruses are the 
major in Pakistan. The prevalence of  hepatitis B is over 
10% in the Asia-pacifi c region where as the prevalence of  
chronic hepatitis C in the Asia-pacifi c region is variable 
between 4 to 12%.1,2
It causes signifi cant morbidity and mortality, mainly due 
to complications like hepatic encephalopathy, ascites, 
hepatorenal syndrome (HRS) and esophageal variceal 
hemorrhage (EVH).3 Hepatic encephalopathy (HE) 
is present in up to 70% of  all patients with cirrhosis, 
including patients with abnormalities demonstrable only by 
psychometric testing,4,5 out of  which about 30% patients 
of  chronic liver disease die of  hepatic encephalopathy.6,7
Hepatic encephalopathy describes a range of  neuropsychiatric 
oddities that occur as a result of  liver failure. The most 
primitive known paper to date on HE is by Giovanni 
Battista Morgagni in eighteenth century. Morgagni’s book 
of  medicine reported the case of  a man with liver cirrhosis 
who had coma and subsequently died, whose gross brain 
examination did not show any alteration (Morgagni 1765).8 
Many ideas generated and struggles are made to fi nd out 
the exact pathophysiology of  H.E. The diversion of  portal 
blood into the systemic circulation through Porto systemic 
collateral vessels is found to be an imperative requirement 
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for the syndrome. It accompanies portal-systemic shunting 
of  venous blood that occurs either spontaneously, due to 
cirrhosis, or non-cirrhotic portal hypertension, or surgically 
following porto-caval anastomosis surgery or trans-jugular 
intra-hepatic porto-systemic shunt (TIPS) aimed at relieving 
portal hypertension.9
A relationship between portal-systemic shunting of  blood 
and behavioral alterations, including coma, was clearly 
proven in porto-caval shunted dogs (i.e., submitted to 
Eck fi stula) by Hahn et al. (1893)10 who demonstrated that 
meat-rich meals could cause ‘encephalitis’.
Many studies also emphasize the role of  neurotoxic agents 
in H.E. Van Caulet in 193211 declared that Ammonia is the 
principal neurotoxin in instigating coma and disturbed brain 
function in patients of  cirrhosis, the same was then proven by 
Sthal in 1936.12 Although many critic focused strictly on the 
involvement of  neurotoxins and it remained controversial for 
a long period of  time but now it is widely accepted that they 
have a certain role in the pathogenesis of  H.E and among 
them ammonia is the toxin of  interest. Ammonia formed 
by the colonic bacteria is carried to the liver via portal vein 
after absorption, where it is incorporated in the urea cycle 
for detoxifi cation. Other gut-derived toxins have also been 
proposed e.g. benzodiazepine like substances, products 
of  colonic bacterial metabolism such as neurotoxic short 
and medium chain fatty acids, phenols and mercaptans and 
manganese. Ammonia and the other substances gain access 
to the systemic circulation as a result of  decreased hepatic 
function or porto-systemic shunts and harmfully disturbs 
brain function and theaters a role in the pathogenesis of  
H. E. In the brain these compounds produce alterations 
of  neurotransmission that affect cognizance and behavior. 
Abnormalities in glutamatergic, serotoninergic, gaminobutyric 
acid-ergic (GABA-ergic) and catecholamine pathways have 
been described in experimental hepatic encephalopathy. The 
role of  ammonia in hepatic encephalopathy is supported by 
the fi nding of  high arterial ammonia level. The permeability 
of  blood-brain barrier for ammonia is increased in patients 
with hepatic encephalopathy. Furthermore, ammonia after 
entering into the astrocytes, is metabolized and leads to 
changes in neurotransmission and hence alters the cellular 
functions. Manganese is deposited in basal ganglia and 
induces extra pyramidal symptomatology. It’s also been 
proposed that an alteration in the ratio of  branch chain 
amino acids and aliphatic amino acids can also predisposes 
to hepatic encephalopathy.13
PATIENTS AND PROCEDURES
Study design and setting
It was a hospital based descriptive, cross sectional 
study, carried out at department of  medicine, ward 5, 
Jinnah Postgraduate Medical Centre, Karachi, from July 
2013 to December 2013. 150 consecutive patients of  
Chronic Liver Disease diagnosed previously or newly 
diagnosed after admission, between the ages of  14 to 
83 years, presenting with encephalopathy were enrolled 
in the study.
Data collection
A Performa was structured and check list was used for 
data collection. Detailed history was obtained with special 
consideration to fever, GI bleed, Burning micturition, 
Diarrhea, vomiting, constipation, abdominal pain and 
distension, jaundice, diet and drugs like sedatives, diuretics 
and cough syrups. Patients were examined with special 
attention to fever, anemia, jaundice, palmar erythema, 
spider nevi, gynaecomastia, asterixis, dehydration, edema, 
splenomegaly and ascites. Relevant hematological, 
biochemical and radiological investigations were ordered 
including complete blood count, urea, creatinine and 
electrolytes, liver function tests, coagulation profi le, serum 
proteins, serum albumin and globulin ratio, HBsAg, Anti 
HCV Antibody, urine D/R, ascitic fl uid D/R, serum 
ammonia, chest X-Ray, ultrasound abdomen, CT Brain 
and upper GI endoscopy. All patients underwent standard 
management during their hospital stay which included use 
of  lactulose, metronidazole, 3rd generation cephalosporin, 
proton pump inhibitor, and vitamin K and FFP in patient 
with deranged coagulation profi le or GI bleed. Ryle’s tube 
for feeding purposes was placed in patients with hepatic 
encephalopathy grade > 2. Outcomes assessed were the 
discharge or death during admission period.
Inclusion criteria
Cirrhosis was diagnosed on the basis of  clinical signs & 
symptoms, laboratory fi ndings (deranged coagulation profi le 
and reversal of  albumin/globulin ratio) and ultrasound 
fi ndings (size and echogenicity of  liver, portal vein diameter, 
splenomegaly), and patients were categorized according to 
Child Pugh classifi cation (Table 1). Diagnosis of  hepatic 
encephalopathy was made on the basis of  history, physical 
examination and number connection test, and was graded 
from I to IV according to the West Haven criteria (Table 2).
Exclusion criteria
Patients suffering from acute liver failure, non cirrhotic 
portal hypertension, intracranial lesions such as subdural 
Table 1: Child pugh classifi cation
1 2 3
Bilirubin (mg/dl) <2 2-3 >3
Serum Albumin (g/dl) >3.5 2.8-3.5 <2.8
Grade of Encephalopathy None Mild Moderate to severe
Grade of Ascites None Mild Moderate to severe
INR <1.2 1.2-1.7 >1.7
Child A: 5-6, Child B: 7-9, Child C: 10-15
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hematoma, cerebral infarction or bleed, meningitis, 
encephalitis, brain abscess, hypoxia, hypercarbia, 
ketoacidosis, neuropsychiatric disorders or post-epileptic 
confusion were excluded from the study.
Operational defi nitions
Constipation was defined as failure to pass stool in 
48 hours, infection as presence of  fever, raised leukocyte 
count, significant pyuria (at greater than or equal to 
10 leucocytes/mm3), >500 TLC or >250 neutrophils in 
ascitic D/R, electrolyte imbalance as high or low level of  
serum sodium or serum potassium as per the reference levels, 
upper gastrointestinal bleed as history of  hematemesis or 
melena, dehydration as presence of  dry tongue and loss of  
skin turgor, high protein diet as recent unrestricted high 
intake of  proteins consumed in any form, renal impairment 
as creatinine of  >2.
Data analysis
Statistical analysis was done using SPSS version 19 and 
the results were obtained in the terms of  frequencies and 
percentages for descriptive analysis. Chi-Square and student 
t tests were used to analyze the numerical data and p value 
of  <0.05 was considered statistically signifi cant.
RESULTS
A total number of  one hundred and fi fty (n = 150) 
adults diagnosed cases of  chronic liver disease who 
presented with hepatic encephalopathy irrespective of  
cause were included, out of  them ninety six (n = 96, 
64%) were females and fi fty four (n = 54, 36%) were 
males. Majority (n = 106, 70%) of  the patients in our 
study belong from middle age group (i.e., 40-60 years 
of  age), with mean age of  52.45 (±12.271) years. The 
age and gender distribution of  the patients is shown in 
Figure 1 & 2.
The most common cause of  chronic liver disease was found 
to be HCV in our patients. Frequency of  viral hepatitis as 
a cause of  chronic liver disease is mentioned in Figure 3.
Out of  150 admitted patients, 107 (71.3%) were discharged, 
while 43 (28.7%) passed away. The frequency of  grade of  
hepatic encephalopathy in our patients is shown in Figure 4.
Table 2: West haven criteria
Grade 1 Mild confusion
Trivial lack of awareness
Euphoria or anxiety
Shortened attention span
Impaired performance of addition
Grade 2 Drowsiness
Lethargy or apathy
Minimal disorientation for time or place
Subtle personality change
Inappropriate behavior
Impaired performance of subtraction
Grade 3 Somnolence but arousable
Marked confusion
Gross disorientation
Grade 4 Coma
(unresponsive to verbal or noxious stimuli)
.
3, 
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133, 
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Non-B, Non-C
HBV
HCV
Both HBV and HCV
Figure 3: Frequency of vital hepatitis as a cause of chronic liver disease
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Figure 1: Gender distribution of patients included in the study
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Figure 2: Age frequency of the patients enrolled in the study
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Sign & symptoms (in the decreasing order of  frequency) 
and the laboratory parameters of  our patients are 
mentioned in the Figure 5 and Table 3.
TLC count was low in 13 (8.66%), normal in 94 (62.66%) 
and high in 43 (28.66%) of  our patients. Urea was 
deranged in 78 (52%), while creatinine was high in 
20 (13.33%) of  the cases. Hypoalbuminema was recorded 
in 118 (78.66%), while deranged coagulation profi le was 
found in 85 (56.66%) of  subjects. Fifty one (51) patients 
in our study presented with GI Bleed comprising of  34% 
of  total cases.
Out of  150 patients, 07 (4.6%) had hypernatremia while 
62 (41.33%) had normal sodium level. Hyponatremia 
was present in 81 (54%) patients. Of  those having 
hyponatremia, 51 patients fall in the category of  mild, 
23 in moderate and 7 had severely low serum sodium. 
Similarly, out of  total 150 patients 07 (4.6%) had 
hyperkalemia while 92 (61.33%) had normal potassium 
level. Hypokaelmia was present in 51 (34%) patients. Of  
those having hypokalemia, 42 patients fall in the category 
of  mild, and 9 had moderately low serum potassium. 
Frequency of  infections and electrolyte imbalances is 
mentioned in the Table 4.
Eighty (53.33%) patients were having constipation. 
Infection was found in 55 (36.66%) cases. Upper GI 
Bleed was present in 51 (34%) patients. 44 (29.33%) 
patients had moderate to severe electrolyte imbalance as 
the cause. Constipation alone was the cause in 11.33% of  
cases. More than one factor was found to be responsible 
in around 56% of  patients while in 6.6% of  cases none 
of  these precipitating factors was isolated.
Grade of  hepatic encephalopathy in our patients was 
directly related with the number of  predisposing factors 
as shown in Table 5.
116
77%
92
61% 80
53%
79
52% 63
42% 51
34% 39
26%
33
22%
27
18%
21
14%
19
12%
19
12% 128%
Figure 5: Sign and symptoms of the patients included in the study
Table 3: Laboratory parameters of all patients 
with hepatic encephalopathy
Minimum Maximum Mean Std. 
deviation
Hemoglobin (mg/dl) 1.7 13.2 8.417 2.1582
TLC (x109/L) 1.8 33.0 9.291 5.9084
Neutrophils (% of WBC) 5 94 75.04 18.562
Platelets 15 388 96.19 63.906
RBS (mg/dl) 61 591 149.63 88.079
Urea (mg/dl) 15 201 61.56 46.069
Creatinine (mg/dl) 0.10 5.20 1.3939 0.97563
Serum Sodium (meq/l) 83.0 153.0 131.840 10.1431
Serum Potassium (meq/l) 1.70 5.94 3.8703 0.96595
Serum Chloride (meq/l) 81.0 127.8 102.518 9.1711
Total Bilirubin (mg/dl) 0.60 26.00 4.3302 4.93379
ALT (u/l) 12 113 37.34 20.899
AST (u/l) 22 304 80.02 60.401
Serum Albumin (mg/dl) 1.6 33.0 3.574 4.0016
A/G ratio 0.4 1.2 0.816 0.1536
PT (sec) 13.0 38.6 20.171 6.5844
INR 1.00 4.10 1.5506 0.63901
Serum Ammonia (μg/dl) 31 388 191.29 94.566
Liver span (cm) 7.3 14.6 11.115 1.9717
Portal vein diameter 0.7 2.0 1.19 0.3210
Spleen size 8.8 18.9 13.43 2.1089
8
5%
44
29%
46
31%
52
35%
Grade – I Grade – II Grade – III Grade – IV
Figure 4: Classification of patients according to the grades of 
encephalopathy
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To assess the severity of  liver disease in our patients, 
Child-Pugh and MELD scoring systems were applied. 
The mean MELD score of  our patients was 17.2 while 
mean Child-Pugh Score was 9.65.
Chi-square test was used to determine the relation of  child’s 
class with mortality rate, and it was found that mortality 
rate was signifi cantly high in child class C patients as shown 
in Tables 6.
The grade of  hepatic encephalopathy at the time of  
presentation was directly related with the outcome 
(P value < 0.001) and is summarized in the Figure 6.
DISCUSSION
A clearly defi ned precipitating factor is usually identifi ed in 
most patients with hepatic encephalopathy and the reversal 
or control of  these factors is a key step in the management. 
The results of  our study showed that 133 patients (88.66%) 
were suffering from Hepatitis C, and 11 patients (7.33%) 
were of  hepatitis B. Since it was a consecutive type of  
sampling, avoiding selection bias, so our fi ndings are in 
conformation with other studies, which also emphasize 
the fact that HCV is a rapidly growing problem and has 
already overtaken HBV in the etiogenesis of  hepatic 
encephalopathy in Pakistan.14,15 A review article by Jafri 
described a rise in frequency of  HCV as a cause of  CLD 
in Pakistan from 16.67% in early nineties to 51-86% over 
a period of  time.16
Constipation was the commonest factor responsible for 
53% cases of  Hepatic encephalopathy in our patients, 
which is close to earlier published studies (as summarized 
in Table 7),17-20 however contradictory with some of  
national and international reports.21-28 High frequency of  
constipation in our population was perhaps due to the 
fact that people of  our country were probably less aware 
of  the importance of  constipation, precipitating hepatic 
encephalopathy.19 Other factors responsible for prevalence 
of  constipation among our setup include dietary restriction, 
poverty, lack of  use or inappropriate dosing of  lactulose 
due to fi nancial constrains, and lack of  education regarding 
role of  diet in chornic liver disease.18,20 Also most of  the 
patient in our study belong middle age group, and that 
increasing age effects the bowel habits, it may partly be the 
reason of  high prevalence of  constipation in our study.21,22 
Liver and brain biopsies were not taken in our study.
Proper guidance about a healthy diet which consists of  
plenty of  fresh fruits and vegetable, foods high in fi ber 
content (including whole-meal bread, whole-wheat cereal 
and some raw bran in cereal or yoghurt), foods that are 
high in Omega-3 fatty acids and adequate fl uid intake to 
avoid dehydration should be provided to all the patients 
of  Chronic liver disease. Exercise is an integral feature of  
Table 4: Frequency of infection
Frequency Percentage
Absent 95 63.33
Present 55 36.66
Malaria 2 3.63
SBP 5 9.09
Gastroenteritis 6 10.9
Others (UTI, RTI) 42 76.36
Table 5: Relation between predisposing factors 
& grade of hepatic encephalopathy
Cause Grade of hepatic 
encephalopathy
Total
I II III IV
None 0 3 2 5 10
Single cause
Bleed 0 0 3 3 6
Infection 0 3 3 4 10
Constipation 0 7 2 8 17
Electrolyte Imbalance 0 2 5 16 23
More than 1 cause 8 29 31 16 84
Total 8 44 46 52 150
Spearman correlation: P value=0.012
Table 6: Relating outcome (mortality) with child 
pugh class
Child-pugh class Total
A B C
Outcome
Discharge 9 53 45 107
Expire 0 11 32 43
Total 9 64 77 150
Pearson’s R=0.022, Spearman correlation: P value=0.022
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Grade -
I
Grade -
II
Grade -
III
Grade -
IV
8 42
39
18
0 2
7
34
Expire Discharge
Figure 6: Grade of hepatic encephalopathy relating with outome in 
terms of mortality
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bowel management programs, and a lack of  physical activity 
is a factor in the development of  constipation in some 
people. Its effectiveness as an intervention to prevent or 
treat constipation, however, has yet to be demonstrated.29
Lactulose is a commonly prescribed agent to relieve 
constipation in patients with chronic liver disease. It has an 
added advantage as a non-absorbable disaccharide inhibiting 
intestinal ammonia production by number of  mechanisms.30,31
Infections like SBP, urinary tract infection and lower respiratory 
tract infection were the 2nd most common factor present in 
37% of  cases corresponds to the study of  Mohammad Tariq 
(2006).32 In West however the infection as a cause of  hepatic 
encephalopathy is not very common, possibly due to more 
awareness and better nutrition status in their patients.
GI bleed was the third most important factor and was 
found in 34% of  patients in our study, which is similar to 
30% found in Mehboob F (2003),6 although lower than 
that reported by zakaria.21
Electrolyte imbalance was found in 29% patients. Among 
electrolytes, hyponatremia was much more common than 
hypokalemia in our patients which was consistent with the 
fi ndings of  Alam,24 but contradicts with those ofAhmed.19 
Electrolyte imbalances also correlate with the severity of  
the liver disease.33
In our study, sedatives and Tranquilizers were not in use 
of  any patient, and the history taken from the attendants 
and patients themselves were not suggestive of  any self  
prescription of  such drugs. In this study the majority of  
patients are in age group of  50 to 60 and the female were 
dominant, which is contradictory with the fi ndings observed 
in a retrospective study, of  hepatic encephalopathy in Saudi 
Arabia34 and in civil hospital Hyderabad.13
When grading of  encephalopathy is considered, in grade 3 
and 4 electrolyte imbalance is the single most common 
precipitating factor involved.
The mortality rate of  hepatic encephalopathy is high as 
shown by the study of  Sargent et al35 whereas, in our study 
the mortality was 29% and the majority were, Class C, 
Child- Pugh classifi cation. Patients with chronic HE are 
known to have better long term (5 years) survival than those 
who develop HE acutely (100% vs. 70% survival).36 But this 
Table 7: Comparison of our study with past literature (fi gures in percentages)
Author/Place/Year n Constipation INF SBP Diarrhea Malaria Other 
infections 
(RTI, UTI)
GI 
Bleed
Low 
Na+
Low 
K+
Azotemia None 1 cause >1 cause
Present Study/JPMC 
Karachi/2013
150 53 36.66 3.33 12 1.33 28 34 54 34 52 6.66 37 56
Mahboob6 - 19 47 - 5 - - 30 - - - - - -
Bikha Ram Devrajani13/
LUMHS Jamshoro/2007
87 49 67 - - - - 45 - 33 - 6 - -
Akhtar Ali Baloch17/
CHK/2009
190 49.5 38.9 - - - - 32.6 - - - - - -
Naila Masood18/LUMHS 
Jamshoro/2009
90 31.1 27.8 - - - - 10 13.3 37.8 - 13.3 - -
Hameed Ahmed19/
Lady Reading Hosp. 
Peshawar
50 52 - - 22 - - 56 28 68 - - - -
Saira Afzal20/KEMU 
Lahore/2005-06
50 60 10 - - - - 18 - - - - - -
Col. Dr. Manzar 
Zakaria21/CMH 
Lahore/2007
80 6.3 27.5 - - - - 56.3 - - - 8.8 - -
Khalid Mumtaz22/AKUH 
Karachi/2005-07
404 18.3 - 20.5 - - 15.3 13.6 3 6.4 - - 53 35
Dileep k. Rohra23/
CHK/2006
256 12.1 - 10.9 - - 9 15.2 - - - 50.8 - -
Intekhab Alam24/Lady 
Reading Hospital 
Peshawar/2005
50 32 24 - 40 - - 22 38 18 - - - -
Imran Ahmed25/CMH 
Okara/2005
43 20.9 7 - - - - 37.2 - 14 - 9.3 - -
Souheil26 100 3 3 - - - - 18 - 11 - - - -
Faloon & Evans27 39 6 - - - - - 33 - 18 33 3 - -
Conn & Liebertha28 1000 3 4 - - - - 18 - 9 30 2 - -
M. Tariq32/Khyber 
Teaching Hospital 
Peshawar/2006
200 30 30 8 3 - 22 29 1.5 4.5 - - - -
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survival can be improved as appropriate treatment and care 
can cause complete recovery especially if  encephalopathy 
is elicited by a rescindable cause. So there is a defi nite 
need for health education in patients regarding the risk 
of  HE and its precipitating factors, as lack of  awareness 
about this life threatening complication of  CLD is itself  a 
cause of  acquiring hepatic encephalopathy. So a constant 
need and effort to obviate them by all possible measures is 
necessary. Proper dietary advice must be an important part 
of  all counseling practices to chronic liver disease patients.
CONCLUSION
Constipation is the commonest cause of  hepatic 
encephalopathy followed by infection, upper GI bleed 
and electrolyte imbalance. Control of  constipation is very 
imperative in the avoidance of  hepatic encephalopathy 
in our setup. The leading cause of  constipation is a 
poor diet – poor choice of  foods, or irregular eating. Patient 
counseling is a key competency element in its prevention. In 
most cases, simple changes in diet and lifestyle as described 
above can help relieve symptoms and manage constipation, 
and so very effectively prevent the development of  this life 
threatening complication of  cirrhosis.
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